Nodular Lymphocyte-predominant Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Nodular Lymphocyte-predominant Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial [Phase 2]
A National Cancer Institute–sponsored Phase 2 trial (NORM) is evaluating rituximab versus mosunetuzumab in nodular lymphocyte-predominant ly…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
A clinical trial update noting that study NCT06098430 is recruiting to assess patient-reported outcomes and quality of life in adults and ch…